The three main types of juvenile macular degeneration (JMD) include Stargardt disease, X-linked retinoschisis, and Best disease. These result from gene mutations. Early treatment may help preserve ...

Myopic macular degeneration (MMD) is a serious eye condition that can cause vision loss that gets worse over time. Treatment may help reduce complications of MMD. Myopic macular degeneration (MMD ...

The Food and Drug Administration (FDA) has approved Encelto ™ (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel). MacTel is a rare, progressive eye disease that ...

Encelto is the first FDA-approved treatment for macular telangiectasia type 2. The cell therapy slows the loss of macular photoreceptors through continuous delivery of ciliary neurotrophic factor.

Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration. You may have vision loss that happens over time. Here’s what you can expect. With GA, you get blind spots in ...

Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months. ENCELTO is anticipated to be available in the US by June 2025, offering hope for ...

The approval was based on results from two phase 3 trials which demonstrated that after placement, of the implant, ENCELTO significantly slowed the loss of macular photoreceptors in MacTel patients ...

Advert Age-related macular degeneration (AMD) is an eye disease that can blur your central vision, and is leading cause of vision loss for older adults, according to the National Eye Institute. It ...

Most of us take our eyesight for granted and yet, if you’re among the 10 million people in the U.S. with low-vision due to age-related macular degeneration (AMD), reading, writing, and other ...

Fibroid degeneration occurs when a uterine fibroid outgrows its limited blood supply and begins to die. Fibroids are benign uterine growths made of smooth muscle cells and fibrous tissue. Some people ...

Macular ganglion cell complex (GCC) thinning, as observed using swept-source optical coherence tomography (SS-OCT), can serve as a noninvasive marker for evaluating visual dysfunction following ...